{
    "hands_on_practices": [
        {
            "introduction": "A primary role of government in public health is to prevent and control the spread of infectious diseases. This practice delves into herd immunity, a cornerstone of modern vaccination strategy, which occurs when a sufficient portion of a population is immune to an infection, thereby providing indirect protection to those who are not immune. By working through the calculation of a minimum vaccination coverage target using the basic reproduction number ($R_0$) and vaccine effectiveness, you will gain hands-on experience in how governments use fundamental epidemiological models to set evidence-based policy goals for national immunization programs .",
            "id": "4569872",
            "problem": "A national public health agency is setting a vaccination coverage target as part of a government-led infectious disease control program. Consider a pathogen with a Basic Reproduction Number (BRN, denoted $R_0$) and a mass vaccination campaign using a vaccine whose Vaccine Effectiveness against infection (VE) is the proportional reduction in susceptibility among vaccinated individuals relative to unvaccinated individuals. Assume homogeneous mixing, that vaccination is randomly distributed in the population, and that vaccine action is limited to reducing susceptibility to infection (that is, it does not change the infectiousness of vaccinated individuals who become infected).\n\nStarting from the core epidemiological definition that the Effective Reproduction Number (denoted $R_e$) equals the product of the Basic Reproduction Number and the average fraction of the population that remains susceptible, herd immunity is achieved when $R_e1$. Use this principle and the above assumptions to derive the minimum vaccination coverage fraction, denoted $c_{\\min}$, required for herd immunity in terms of $R_0$ and VE. Then, evaluate this expression for $R_0=4$ and $\\text{VE}=0.80$. Express your final answer for the minimum coverage as a fraction or a decimal number. Do not use a percent sign.",
            "solution": "The problem statement is scientifically grounded, well-posed, and free of contradictions. All necessary definitions and parameters are provided to derive a unique and meaningful solution. Therefore, the problem is deemed valid.\n\nThe objective is to derive an expression for the minimum vaccination coverage, $c_{\\min}$, required to achieve herd immunity and then to evaluate it for the given parameters. The condition for herd immunity is that the effective reproduction number, $R_e$, must be less than $1$. The threshold for minimum coverage is therefore found by setting $R_e = 1$.\n\nThe problem states that the effective reproduction number is the product of the basic reproduction number, $R_0$, and the average fraction of the population that remains susceptible, which we will denote as $S_{avg}$.\n$$R_e = R_0 \\times S_{avg}$$\n\nWe must first determine the expression for $S_{avg}$. Let $c$ be the fraction of the population that is vaccinated. The fraction that is unvaccinated is then $(1-c)$. The population is thus divided into two groups.\n\nThe susceptibility of each group must be defined. We can set the relative susceptibility of an unvaccinated individual to $1$. The problem defines Vaccine Effectiveness, VE, as the proportional reduction in susceptibility for vaccinated individuals. If $S_u$ is the susceptibility of the unvaccinated and $S_v$ is the susceptibility of the vaccinated, then:\n$$\\text{VE} = \\frac{S_u - S_v}{S_u}$$\nSetting the baseline susceptibility of the unvaccinated to $S_u = 1$, the susceptibility of a vaccinated individual, $S_v$, becomes:\n$$\\text{VE} = \\frac{1 - S_v}{1} \\implies S_v = 1 - \\text{VE}$$\n\nThe average susceptibility of the entire population, $S_{avg}$, is the weighted average of the susceptibilities of the two groups, where the weights are the fractions of the population in each group.\n$$S_{avg} = (\\text{fraction unvaccinated}) \\times S_u + (\\text{fraction vaccinated}) \\times S_v$$\nSubstituting the expressions for the fractions and susceptibilities:\n$$S_{avg} = (1-c) \\cdot 1 + c \\cdot (1 - \\text{VE})$$\nThis expression simplifies to:\n$$S_{avg} = 1 - c + c - c \\cdot \\text{VE}$$\n$$S_{avg} = 1 - c \\cdot \\text{VE}$$\n\nNow, we substitute this expression for $S_{avg}$ back into the equation for $R_e$:\n$$R_e = R_0 (1 - c \\cdot \\text{VE})$$\n\nTo find the minimum vaccination coverage, $c_{\\min}$, that ensures herd immunity ($R_e  1$), we solve for the critical threshold where $R_e = 1$.\n$$1 = R_0 (1 - c_{\\min} \\cdot \\text{VE})$$\nWe can now solve this equation for $c_{\\min}$:\n$$\\frac{1}{R_0} = 1 - c_{\\min} \\cdot \\text{VE}$$\n$$c_{\\min} \\cdot \\text{VE} = 1 - \\frac{1}{R_0}$$\n$$c_{\\min} = \\frac{1 - \\frac{1}{R_0}}{\\text{VE}}$$\nThis can be written in a more compact form:\n$$c_{\\min} = \\frac{\\frac{R_0 - 1}{R_0}}{\\text{VE}} = \\frac{R_0 - 1}{R_0 \\cdot \\text{VE}}$$\nThis is the general expression for the minimum vaccination coverage required for herd immunity, given a vaccine that is not perfectly effective at preventing infection.\n\nThe final step is to evaluate this expression for the given values: the Basic Reproduction Number $R_0 = 4$ and the Vaccine Effectiveness $\\text{VE} = 0.80$.\n$$c_{\\min} = \\frac{4 - 1}{4 \\cdot 0.80}$$\n$$c_{\\min} = \\frac{3}{3.2}$$\nTo express this as a simple fraction or decimal, we can write:\n$$c_{\\min} = \\frac{3}{\\frac{32}{10}} = \\frac{30}{32} = \\frac{15}{16}$$\nAs a decimal, this is:\n$$c_{\\min} = 0.9375$$\nThis means that a minimum of $93.75\\%$ of the population must be vaccinated to achieve herd immunity under the given conditions.",
            "answer": "$$\\boxed{0.9375}$$"
        },
        {
            "introduction": "Governments operate with finite budgets and must make rational, evidence-based decisions on which health interventions to fund. This exercise introduces you to cost-effectiveness analysis, a core framework in health economics that allows policymakers to compare the value of a health program to its cost. By calculating the Incremental Cost-Effectiveness Ratio (ICER) for a cancer screening program and applying a willingness-to-pay threshold, you will simulate the decision-making process that determines whether a new public health initiative is a sound investment of taxpayer money .",
            "id": "4569831",
            "problem": "A national health ministry is evaluating whether to adopt a new government-funded colorectal cancer screening program. The program would be scaled nationally if it is considered cost-effective under the ministryâ€™s explicit willingness-to-pay threshold per quality-adjusted life year (QALY). The evaluation uses the following widely accepted foundations in public decision-making for preventive medicine: (i) a QALY (quality-adjusted life year) is a measure of health benefit that combines length and quality of life; (ii) the incremental cost $\\Delta C$ is the additional cost of the new program relative to current practice; (iii) the incremental effect $\\Delta E$ is the additional QALYs gained by the new program relative to current practice; and (iv) a central decision rule in government health technology assessment is to compare the value of health gained to its cost using a willingness-to-pay threshold per QALY.\n\nFor this program, the best available evidence indicates an incremental cost of $\\Delta C = \\$5,000$ per person and an incremental effect of $\\Delta E = 0.2$ QALYs per person. The ministry uses a willingness-to-pay threshold of $\\lambda = \\$50,000$ per QALY.\n\nUsing these foundations, compute the incremental cost-effectiveness ratio (ICER) and determine whether the program is acceptable for adoption under the threshold $\\lambda$. For the answer box, report only the ICER value, rounded to three significant figures, and express it in United States dollars per quality-adjusted life year (QALY).",
            "solution": "The problem statement is evaluated and found to be valid. It is scientifically grounded in the principles of health economics, specifically cost-effectiveness analysis, a standard methodology for public health decision-making. The problem is well-posed, objective, and contains all necessary information to derive a unique and meaningful solution.\n\nThe primary task is to compute the Incremental Cost-Effectiveness Ratio (ICER) and then use it to make a decision about a health program's adoption. The ICER is defined as the ratio of the incremental cost ($\\Delta C$) of an intervention to its incremental effect ($\\Delta E$):\n$$\n\\text{ICER} = \\frac{\\Delta C}{\\Delta E}\n$$\nIn this context, $\\Delta C$ represents the additional cost per person, and $\\Delta E$ represents the additional health benefit measured in Quality-Adjusted Life Years (QALYs) per person.\n\nThe problem provides the following values:\n- The incremental cost is $\\Delta C = \\$5,000$.\n- The incremental effect is $\\Delta E = 0.2$ QALYs.\n\nSubstituting these given values into the ICER formula yields:\n$$\n\\text{ICER} = \\frac{\\$5,000}{0.2 \\text{ QALYs}}\n$$\nThe calculation is performed as follows:\n$$\n\\text{ICER} = \\frac{5000}{0.2} = \\frac{5000}{\\frac{2}{10}} = 5000 \\times \\frac{10}{2} = 5000 \\times 5 = 25,000\n$$\nThe units of the ICER are dollars per QALY, so the ICER of the proposed program is $\\$25,000$ per QALY.\n\nThe next step is to apply the decision rule. A program is considered acceptable or \"cost-effective\" if its ICER is less than or equal to the health ministry's willingness-to-pay threshold, $\\lambda$. The decision criterion is expressed as:\n$$\n\\text{ICER} \\le \\lambda\n$$\nThe problem states that the ministry's threshold is $\\lambda = \\$50,000$ per QALY. We compare our calculated ICER to this threshold:\n$$\n\\$25,000 \\text{ per QALY} \\le \\$50,000 \\text{ per QALY}\n$$\nThe inequality is true. Since the ICER of the colorectal cancer screening program is below the established willingness-to-pay threshold, the program is considered cost-effective and is therefore acceptable for adoption.\n\nThe final answer requires reporting the ICER value rounded to three significant figures. The calculated value is exactly $25,000$. To represent this integer with a precision of three significant figures, it is best expressed in standard scientific notation. The first three significant digits are $2$, $5$, and $0$.\n$$\n25,000 = 2.50 \\times 10^{4}\n$$\nThis format unambiguously communicates the required precision.",
            "answer": "$$\n\\boxed{2.50 \\times 10^{4}}\n$$"
        },
        {
            "introduction": "Beyond providing direct services, governments can use economic instruments to influence behaviors that have broad public health consequences. This practice explores the use of a Pigouvian tax to address the negative externality of antimicrobial resistance, a growing global health crisis fueled by the overuse of antibiotics. By calculating the optimal tax to align the private cost of antibiotics with their true social cost, you will see how governments can harness microeconomic principles to safeguard public health and preserve the effectiveness of critical medicines for future generations .",
            "id": "4569667",
            "problem": "A national public health authority is considering a Pigouvian policy to internalize the antimicrobial resistance externality associated with community antibiotic consumption. Let the market for antibiotics be competitive so that the pre-tax consumer price equals the private marginal cost. The government aims to set a uniform per-unit tax so that private decision-makers face the full social marginal cost.\n\nSuppose the following empirically grounded quantities hold for the target antibiotic class:\n- Baseline use is 1,000 Defined Daily Dose (DDD) per 1,000 inhabitants.\n- The marginal external cost due to antimicrobial resistance is constant at 10 United States Dollar (USD) per DDD.\n- The pre-tax consumer price is 20 USD per DDD.\n- The price elasticity of demand (PED) for this antibiotic class is constant and equal to $-0.5$ over the relevant price range.\n\nAssume full pass-through of the tax to the consumer price and no change in supply conditions other than the tax. Using fundamental welfare principles and the definition of price elasticity of demand, determine:\n1) the optimal per-unit tax that internalizes the external cost, in USD per DDD, and\n2) the predicted new level of antibiotic use in DDD per 1,000 inhabitants after the tax is imposed.\n\nExpress the optimal tax in USD per DDD and the new use level in DDD per 1,000 inhabitants. Round both results to three significant figures.",
            "solution": "The problem statement is evaluated to be scientifically grounded, well-posed, objective, and internally consistent. It is a valid microeconomic problem based on established principles of welfare economics applied to public health.\n\nThe problem requires the determination of two quantities: the optimal per-unit Pigouvian tax and the resulting new level of antibiotic consumption. We will address each in turn.\n\nLet $Q$ be the quantity of antibiotics consumed in Defined Daily Dose (DDD) per $1,000$ inhabitants, and let $P$ be the price in United States Dollars (USD) per DDD. The given baseline (pre-tax) state is characterized by:\n- Baseline use: $Q_0 = 1000$ DDD per $1,000$ inhabitants.\n- Pre-tax price: $P_0 = 20$ USD per DDD.\n\nThe problem states that the market is competitive, so the pre-tax price equals the private marginal cost ($PMC$).\n$$PMC = P_0 = 20$$\nA negative externality in the form of antimicrobial resistance is present, with a constant marginal external cost ($MEC$).\n$$MEC = 10$$\nThe social marginal cost ($SMC$) is the sum of the private marginal cost and the marginal external cost.\n$$SMC = PMC + MEC$$\n\n**1) Optimal Per-Unit Tax ($t^*$):**\n\nThe fundamental principle of a Pigouvian tax is to internalize an externality by setting a per-unit tax, $t$, equal to the marginal external cost at the socially optimal level of output. The goal is to align the private cost faced by consumers with the true social cost of their consumption.\n\nBy imposing a tax $t$, the new price faced by the consumer, $P_1$, becomes $P_1 = PMC + t$. For the private decision-maker to face the full social marginal cost, this new price must be equal to the social marginal cost.\n$$P_1 = SMC$$\nSubstituting the expressions for $P_1$ and $SMC$:\n$$PMC + t = PMC + MEC$$\nThis directly implies that the optimal tax, $t^*$, must be equal to the marginal external cost.\n$$t^* = MEC$$\nThe problem states that the $MEC$ is constant and equal to $10$ USD per DDD. Therefore, the optimal per-unit tax is:\n$$t^* = 10$$\nRounding to three significant figures as requested, the optimal tax is $10.0$ USD per DDD.\n\n**2) New Level of Antibiotic Use ($Q_1$):**\n\nWith the optimal tax $t^* = 10$ imposed, we can determine the new consumer price, $P_1$. The problem specifies full pass-through of the tax, meaning the entire tax burden is shifted to consumers in the form of a higher price.\n$$P_1 = P_0 + t^* = 20 + 10 = 30$$\nThe new price is $30$ USD per DDD.\n\nTo find the new quantity consumed, $Q_1$, at this new price, we use the given price elasticity of demand ($\\epsilon$), which is stated to be constant and equal to $-0.5$.\n$$\\epsilon = -0.5$$\nA constant price elasticity of demand implies that the demand function is of the form $Q(P) = k P^{\\epsilon}$ for some constant $k$. From this functional form, we can establish a precise relationship between two points $(P_0, Q_0)$ and $(P_1, Q_1)$ on the demand curve.\n$$Q_0 = k P_0^{\\epsilon}$$\n$$Q_1 = k P_1^{\\epsilon}$$\nDividing the second equation by the first eliminates the constant $k$:\n$$\\frac{Q_1}{Q_0} = \\frac{k P_1^{\\epsilon}}{k P_0^{\\epsilon}} = \\left(\\frac{P_1}{P_0}\\right)^{\\epsilon}$$\nThis equation allows us to calculate the new quantity $Q_1$ based on the initial state and the price change.\n$$Q_1 = Q_0 \\left(\\frac{P_1}{P_0}\\right)^{\\epsilon}$$\nSubstituting the known values:\n- $Q_0 = 1000$\n- $P_0 = 20$\n- $P_1 = 30$\n- $\\epsilon = -0.5$\n\n$$Q_1 = 1000 \\left(\\frac{30}{20}\\right)^{-0.5} = 1000 \\left(1.5\\right)^{-0.5}$$\n$$Q_1 = 1000 \\times \\frac{1}{\\sqrt{1.5}} = 1000 \\times \\frac{1}{\\sqrt{3/2}} = 1000 \\times \\sqrt{\\frac{2}{3}}$$\nNow, we compute the numerical value:\n$$Q_1 \\approx 1000 \\times \\sqrt{0.6666...} \\approx 1000 \\times 0.81649658...$$\n$$Q_1 \\approx 816.49658...$$\nThe problem requires rounding the result to three significant figures.\n$$Q_1 \\approx 816$$\nThus, the predicted new level of antibiotic use is $816$ DDD per $1,000$ inhabitants.",
            "answer": "$$\\boxed{\\begin{pmatrix} 10.0  816 \\end{pmatrix}}$$"
        }
    ]
}